2023 marked the first year in nearly three decades that overall alcohol sales volumes declined
While GLP-1 (glucagonlike peptide 1) agonist drugs such as semaglutide target a single hormone receptor that regulates hunger, GLP-3s target multiple receptors, including GLP-1, the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon receptor
These behavioral improvements, when paired with physiologic hunger reduction, support a more sustainable approach to weight loss than either medication alone
These include nausea, vomiting, diarrhoea, and abdominal discomfort
MOTS-C: a mitochondrial-derived peptide that improves insulin sensitivity and metabolic efficiency, particularly relevant for patients with metabolic syndrome or pre-diabetes alongside weight loss goals
It helps control sex drive and plays a role in getting an erection